Radcliffe Capital Management’s VSee Health Warrant VSEEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100,000
Closed -$2.35K 246
2023
Q3
$2.35K Hold
100,000
﹤0.01% 452
2023
Q2
$6.66K Hold
100,000
﹤0.01% 470
2023
Q1
$9K Hold
100,000
﹤0.01% 557
2022
Q4
$1.07M Hold
100,000
0.03% 646
2022
Q3
$1.01M Hold
100,000
0.02% 896
2022
Q2
$1M Hold
100,000
0.02% 941
2022
Q1
$1M Buy
+100,000
New +$23.4K 0.02% 931

Other funds holding VSEEW

Radcliffe Capital Management's VSEEW Position: Q4 2023 in Review

Radcliffe Capital Management sold out of VSee Health Warrant (VSEEW) in Q4 2023, closing a stake of 100,000 shares — an estimated $2.35K sold.

Radcliffe Capital Management first reported a position in VSEEW in Q1 2022 and held it in 7 quarters. The position peaked at $1.07M in Q4 2022. 28 funds tracked by Wall St. Rank hold VSEEW as of Q4 2023.

  • Radcliffe Capital Management reported no remaining VSee Health Warrant position as of Q4 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 100,000 VSee Health Warrant shares in Q4 2023, an estimated $2.35K.
  • Radcliffe Capital Management first reported a position in VSee Health Warrant in Q1 2022 and held it in 7 quarters.
  • Radcliffe Capital Management's VSee Health Warrant position peaked at $1.07M in Q4 2022.
  • 28 funds tracked by Wall St. Rank held VSee Health Warrant as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.